Nature Biotechnology 2001 |
Title | Subject | Authors |
A biodegradable polymer as a cytokine delivery system for inducing bone formation. | Business | et al, Naoto Saito |
A clearer vision for in vivo imaging.(Progress continues in the development of smaller, more penetrable probes for biological imaging.) | Business | Ralph Weissleder |
Adding new meanings to the genetic code.(Two New Approaches Offer the Means to Expand the Repertoire of Amino Acids Available for Protein Engioneering) | Business | Nina Mejhede |
A DNA computing readout operation based on structure-specific cleavage.(Research article)(Illustration) | Business | Liman et al Wang |
Affinity capture of proteins from solution and their dissociation by contact printing. | Business | Peter Sonderegger, Andre Bernard, Dora Fitzli, Emmanuel Delamarche, Bruno Michel, Hans Rudolf Bosshard, Hans Biebuyck |
A high signal-to-noise Ca2 probe composed of a single green fluorescent protein. | Business | Junichi Nakai, Masamichi Ohkura, Keiji Imoto |
A high-throughput alphavirus-based expression cloning system for mammalian cells. | Business | Daniel et al Koller |
Alteration of Cre recombinase site specificity by substrate-linked protein evolution.(Research article)(Illustration) | Business | Frank and Stewart Buchholz A. Francis |
A method for the amidation of recombinant peptides expressed as intein fusion proteins in Escherichia coli.(Illustration)(Statistical Data Included) | Business | Alan Colman, Ian R. Cottingham, Alan Millar, Elisabeth Emslie, Angelika E. Schnieke, Colin McKee |
A motif-based profile scanning approach for genome-wide prediction of signaling pathways. | Business | et al, Michael B. Yaffe |
An industry imperiled by regulatory bottlenecks.(stem and immune cell treatments) | Business | Gail Naughton |
An infectious transfer and expression system for genomic DNA loci in human and mouse cells.(Technical report)(Illustration) | Business | Richard et al Wade-Martins |
An intellectual property clearinghouse for agricultural biotechnology.(proposing a means for sharing intellectual property while preserving patent rights) | Business | David Zilberman, Gregory Graff |
Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II-peptide chimera. | Business | Sofia Casares, Alexandru C. Stan, Constantin A. Bona |
A peptide carrier for the delivery of biologically active proteins into mammalian cells. | Business | May C. et al Morris |
A RACHITT for our toolbox.(A new twist on DNA suffling increases recombination frequency and expands access to sequence space, facilitating the engineering of new protein activities.) | Business | Joelle N. Pelletier |
A sensitive transgenic plant system to detect toxic inorganic compounds in the environment. | Business | Olga et al Kovalalchuk |
A systemic approach to the analysis of protein phosphorylation. | Business | Ruedi Aebersold, Julian D. Watts, Luilin Zhou |
Aurora throws light on Vertex's aspirations.(Vertex Pharmaceuticals)(Aurora Biosciences) | Business | |
A yeast sensor of ligand binding.(Research article)(Illustration) | Business | Chandra L. and Fields ucker Stanley |
Bactericidal antisense effects of peptide-PNA conjugates. | Business | et al, Liam Good |
Bar-coding ciomolecules with fluorescent nanocrystals.(Microbeads embedded w/ quantum dots) | Business | Sandra J. Rosenthal |
Beyond comparison - antibiotics from genome data? Microbial genomics is producing a plethora of candidate targets for developing new classes of antimicrobial agents. | Business | Michael N. Alekshun |
Big pharmas seek biotechs that deliver. | Business | |
Bioassay of prostate-specific antigen (PSA) using microcantilevers. | Business | Guanghua Wu, Ram H. Datar, Karolyn M. Hansen, Thomas Thundat, Richard J. Cote, Arun Majumdar |
Bioethics programs evolve as they grow. | Business | David Magnus |
Biotech industry faces new bottleneck. | Business | Ken Garber |
Biotechnology in the Baltic.(Estonia is Using its Genes as Bait for Foreign Investments to Support its Embryonic Biotechnology Industry) | Business | Frank Lone |
Biotechnology patents in the food sectors.(A closer look at the field, the players, and their strategies reveals a game of follow the leader.) | Business | Shyana V. Ramani |
Breaking the code of resistance.(insect pests' resistance to Bacillus thuringiensis)(Illustration) | Business | Bruce E. Tabashnik |
Bungled law threatens Italian tech transfer.(New legislation from the Italian goverment)(Statistical Data Included) | Business | Anna Meldolesi |
Canadian farmer found guilty of Monsanto canola patent infringement. | Business | |
Can bioremediation bounce back? As the market for bioremediation using genetically modified microorganisms is eroded by controversy over the technology, transgenic plants may take center stage for environmental cleanup. | Business | Myrna E. Watanabe |
Cell factories for fighting cancer. | Business | Douglas Hanahan, Gabriele Bergers |
Combined transductional and transcriptional targeting improves the specificity of transgene expression "in vivo." | Business | Paul N. et al Reynolds |
Comples biology with no parameters.(Human genome sequence) | Business | James E. Bailey |
Crafting crop resistance to corn rootworms.(Transgenic corn) | Business | Ken Ostlie |
CREating breakthroughs.(utilizing a recombinant Cre recombinase)(Illustration) | Business | Chun-Ming Chen, Richard C. Behringer |
Designing an optimal intellectual property system for plants: a US Supreme Court debate.(Illustration) | Business | Mark D. Janis, Jay P. Kesan |
Designing a polyvalent inhibitor of anthrax toxin.(Illustration)(Statistical Data Included) | Business | George M. Whitesides, Michael Mourez, Ravi S. Kane, Jeremy Mogridge, Steve Metallo, Pascal Deschatelets, Bret R. Sellman, R. John Collier |
Differentiation and integration.(Mergers and acquisitions likened to the product of incremental quantities)(Brief Article) | Business | |
Direct and sensitive detection of a human virus by rupture event scanning. | Business | Matthew A. et al Cooper |
Disease genes less elusive than once thought, say researchers. | Business | Christopher Morrison |
DNA shuffling method for generating highly recombined genes and evolved enzymes. | Business | et al, Wayne M. Coco |
Drug discovery--an operating model for a new era. | Business | Scott Myers, Ann Baker |
Efficient metaphase II transgenesis with different transgene archetypes.(Technical report)(Illustration) | Business | Anthony C.F. et al Perry |
Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. | Business | Yoshida Oda, Takeshi Nagasu, Brian T. Chait |
Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase.(Illustration) | Business | Daewoong Jo, Abudi Nashabi, Christie Doxsee, Qing Lin, Derya Unutmaz, Jin Chen, H. Earl Ruley |
Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. | Business | et al, Timothy R. Hughes |
Feeder-free growth of undifferentiated human embryonic stem cells.(Illustration)(Statistical Data Included) | Business | Chunhui Xu, Margaret S. Inokuma, Jerrod Denham, Kathaleen Golds, Pratima Kundu, Joseph D. Gold, Melissa K. Carpenter |
Genetic rescue of an endangered mammal by cross-species nuclear transfer using post-mortem somatic cells.(Illustration) | Business | Michael Clinton, Pasqualino Loi, Grazyna Ptak, Barbara Barboni, Josef Fulka Jr., Pietro Cappai |
Genetic selection and the lure of SIN.(A rapid method for exploring gene function uses alphavirus expression cloning) | Business | Garry P. Nolan |
Genotyping of dinucleotide tandem repeats by MALDI mass spectrometry of ribozyme-cleaved RNA transcripts. | Business | Martin Forster, Stefan Krebs, Doris Seichter |
GlaxoSmithKline presents a biotech facade. | Business | Dorey. Emma |
Going for the big one: blockbuster patents enrich university coffers, but can also affect future patenting and research divisions. | Business | |
Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria. | Business | Michael et al Karlberg |
Growing better blod vessels.(Methods for engineering mature blood vessels) | Business | Peter and Conway Carmeliet Edward M. |
Growing pains for biopharmaceuticals. Biopharmaceuticals have provided a swift means of swelling pharmaceutical company pipelines, but they may not be such a fast "fix" for the industry in the future. | Business | Gabby Ashton |
High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain. | Business | H. Michael et al Keyoung |
Holistic approaches to glycobiology.(The Genetic Selection of Mutant Cells in a Glycoconjugate Biosyntheitc Pathway may Provide Insights into Metabolic Disease) | Business | Pauline et al Rudd |
Hotwiring biosensors.(integrated circuits with biomolecules)(Illustration) | Business | |
Illegal Bt cotton in India haunts regulators. | Business | KS Jayaraman |
Immobilized RNA switches for the analysis of complex chemical and biological mixtures. | Business | et al, Sukeerthi Seetharaman |
Indian regulatory system stifles industry growth. | Business | KS Jayaraman |
Indian seed bill forges new ground. | Business | K.S. Jayaraman |
Informatics and multiplexing of intact protein identification in bacteria and the archaea.(Illustration)(Statistical Data Included) | Business | Fanyu Meng, Bengamin J. Cargile, Leah M. Miller, Andrew J. Forbes, Jeffrey R. Johnson, Neil L. Kelleher |
In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. | Business | Jeremy S. Edwards, Rafael U. Ibarra, Bernhard O. Palsson |
In vitro differentiation of transplantable neural precursors from human embryonic stem cells. | Business | Su-Chun et al Zhang |
In vitro selection of necleoprotein enzymes. | Business | Michael P. Robertson, andrew D. Ellington |
In vivo near-infrared fluorescence imaging of osteoblastic activity. | Business | Atif et al Zaheer |
Isjolation of high-affinity ligand-binding proteins by periplasmic expression with cytometric screening (PECS). | Business | Gang et al Chen |
Italy performs GMO trial about-face. | Business | Anna Meldolesi |
Knockout drug screens.(recognizing compounds with gene-selective properties)(Illustration) | Business | George C. Prendergast |
Listening for viral infection. | Business | Paul W.H.I. Parren, Erica Ollmann |
Living on the edges.(molecular component interactions) | Business | Harvey Bialy |
Local endostatin treatment of gliomas administered by microencapsulated producer cells. | Business | Rupert Timpl, Tracy-Ann Read, Dag R. Sorensen, Rupavathana Mahesparan, Per Enger, Bjorn R. Olsen, Mari H.B. Hjelstuen, Olav Haraldseth, Rolf Bjerkvig |
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. | Business | Jeff W.M. et al. Bulte |
Market woes drag down biotech shares.(Brief Article)(Statistical Data Included) | Business | |
Molecular biology meets microelectronics. | Business | Erwin Neher |
Monoclonal antibodies in the clinic.(Despite initial teething problems, the number of clinically effective monoclonal antibodies is growing.) | Business | Janice M. Reichert |
More biotechs gamble on convertibles. | Business | Pete Mitchell |
Multiphoton-evoked color change of DsRed as an optical highlighter for cellular and subcellular labeling. | Business | Jonathan S. et al Marchant |
Multiplex metallica. Molecular tag made of small metal rods may enable parallel and quantitative single-tube assays. | Business | David J. Lockart, Mark O. Trulson |
Nanopores with a spark for single-molecule detection.(DNA sequencing) | Business | Hui Wang, Daniel Branton |
Neural progenitors from human embryonic stem cells. | Business | Reubinoff et al. |
New Zealand's comprimise calms GMO lobby.(compromise found with the genetically-modified foods lobby) | Business | Cheryl Norrie |
Nonenzymatic autoligation in direct three-color detection of RNA and DNA point mutations. | Business | Yanzheng Xu, Nilesh B. Karalkar, Eric T. Kool |
Nuclear security breached. DNA chemistry may provide a solution to the deceptively difficult problem of enhancing DNA nuclear transport in nonviral vectors.(introduction to article in this this issue by Rebuffat et al) | Business | Jon Wolff |
OECD says industrial biotech not realizing potential.(Organization for Economic Cooperation and Development)(Brief Article) | Business | |
Overexpression of a cyanobacterial fructose-1, 6-/sedoheptulose-1, 7-bisphosphatase in tobacco enhances photosynthesis and growth.(Illustration)(Statistical Data Included) | Business | Yoshiko Miyagawa, Masahiro Tamoi, Shigeru Shigeoka |
PDL's mAb technology finds right timing. | Business | |
Phytodetoxification of TNT by transgenic plants expressing a bacterial nitroreductase.(genetically-modified tobacco plants used to decontaminate soil of TNT) | Business | Nerissa et al Hannink |
Pigs expressing salivary phytase produce low-phosporus manure. | Business | |
Pink water, green plants, and pink elephants. Tobacco has been engineered with a bacterial nitroreductase that facilitates degradation of trinitrotoluene.(introduction to article in this issue by Hannink et al) | Business | Richard B. Meagher |
Plastid engineering bears fruit.(The tomato has been engineered to express in its plastids high levels of a recombinant protein) | Business | Pal Maliga |
Polymeric system for dual growth factor delivery.(Research article)(Illustration) | Business | Ricardson, Thomas P.; Peters, Martin C.; Ennett, Alexandra B. and Mooney, David J. |
Production of calves from G1 fibroblasts.(methods for cloning calves) | Business | Poothappillai et al Kasinathan |
Protein hinges for bioelectronics.(The creation of chemoresponsive bioelectronic sensors) | Business | Itamar illner |
Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein. | Business | Philip J. Thomas, W. Christian Wigley, Rhesa D. Stidham, Nathan M. Smith, John F. Hunt |
Proteomics comes to the surface.(studying protein function on a genome-wide scale) | Business | Gavin MacBeath |
Putting a price on biotechnology.(Many bioentrepreneurs incorrectly estimate the value of their technology by failing ot account adequately for the cost, risk, and time inherent in product development.) | Business | Jeffrey J. Stewart, Peter N. Allison, Ronald S. Johnson |
Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry.(Illustration)(Statistical Data Included) | Business | Ruedi Aebersold, David K. Han, Jimmy Eng, Huilin Zhou |
quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. | Business | Mingyong et al Han |
Quicker drug approvals on the way for Europe. | Business | Sylvia Davidson |
Quorex Pharmaceuticals.(New Antimicrobials Quiet Bacterial Talk) | Business | |
Realism in drug discover - could Cassandra be right?(commentary)(Critical Essay) | Business | David F. Horrobin |
Recent patents in molecular evolution.(list of U.S. patents with brief description, company, etc.) | Business | |
Receptor-targeted optical imaging of tumors with near-infrared flurorescent ligands. | Business | et al, Andraes Becker |
Recombinant maxi-K channels on transistor, a prototype of iono-electronic interfacing. | Business | Bernhard Straub, Elisabeth Meyer, Peter Fromherz |
Redefining priorities in gene-based drug discovery. | Business | Mehran M. Khodadoust, Thomas P. Klein |
Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy.(Reasearch article)(Illustration) | Business | Murali et al Ramachandra |
Regulation and exploitation of genetically modified crops. Functional foods, nutraceuticals, and plant-derived mediciens may improvempublic relations for transgeneic crop technology, but could leave manufacturers with tricky business decisions to make. | Business | et al, Gijs A. Kleter |
Selection of insertional mutants using subgenic-resolution arrays.(Research article)(Illustration) | Business | Vasudeo et al Badarinarayana |
Selective enhancement of gene transfer by steroid-medicated gene delivery. | Business | Alexandre et al Rebuffat |
Shedding light on molecular timing.(use of jellyfish's green fluorescent protein in cellular research) | Business | Fred Schaufele |
Single-mismatch detection using gold-quenched fluorescent oligonucleotides. | Business | Benoit Dubertret, Michel Calame, Albert H. Libchaber |
Single-molecule observation of protein-protein interactions in the chaperonin system. | Business | Masasuke Yoshida, Hideki Taguchi, Taro Ueno, Hisashi Tadakuma, Takashi Funatsu |
Stable, genetic transformation of tomato plastids and expression of a foreign protein in fruit. | Business | Stephanie Ruf, Marita Hermann, Irving J. Berger, Helaine Carrer, Ralph Bock |
Stem cells with brainpower. Two studies demonstrate the efficient generation of brain cells from human ES cells.(introduction to two articles in this issue discussing stem cell research) | Business | Lorenz Studer |
Suppression of a P450 hydroxylase gene in plant trichome glands enhances natural-product-based aphid resistance. | Business | et al, Erming Wang |
Switching nucleic acids for antibodies. Can ribozymes replace antibodies i future array formats for proteomics and metabolomics? | Business | Andrew D. Ellington, David Hoffman, Jay Hesselberth |
The complexities of bioethics.(Commentary) | Business | Richard C. Strohman |
The HIV Tat protein transduction domain improves the biodistribution of Beta- glucuronidase expressed from recombinant viral vectors. | Business | Haibin et al Xia |
The path not taken.(Protein paths) | Business | Edward M. Maracotte |
The potential of nucleic acid repair in functional genomics. | Business | Michael C. Rice, Kirk Czymmek, Eric B. Kmiec |
The right chemistry for marker gene removal? | Business | David W. Ow |
Toward knockout sheep.(The Targeted Disruption of two Genes in Sheep Confirms the Feasibility of Gene TArgeting in large Animals, but Falls Short of Producing Viable Offspring) | Business | Kevin Wells |
Toward the phosphoproteome.(Two chemical protocols for the rapid analysis of protein phosphorylation by mass spectrometry promise to expand the schope of proteomics research.) | Business | Natalie G. Ahn, Katheryn A. Resing |
Training needs in regulatory science for the biopharmaceutical industry. | Business | Larry E. Gundersen |
Transplantation of brain cells assembled around programmable synthetic microenvironment.(Illustration)(Statistical Data Included) | Business | W. Mark Saltzman, Melissa J. Mahoney |
Use of isogenic human cancer cells for high-throughput screening and drug discovery.(Illustration)(Statistical Data Included) | Business | Kenneth W. Kinzler, Bert Vogelstein, Christopher J. Torrance, Vijai Agrawal |
US presidential transition prompts biotech policy frenzy. | Business | Jeffrey Fox |
Vaccines to die for.(Induction of Apoptotic Death by Modified Caspases Enhances the Function of "Naked" DNA Vaccination) | Business | Nicholas P. Restifo |
Vironcology -- not yet, but soon? | Business | Richard G. Vile |
Why biodefense won't work.(The problems of defending against bioterrorism)(Brief Article) | Business | |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.